Advertisement

Development of μ/δ Opioid Ligands: Enkephalin Analogues Containing 4-Anilidopiperidine Moiety

  • YeonSun Lee
  • Ravil Petrov
  • Vinod Kulkarni
  • Byoung J. Min
  • Shou-wu Ma
  • Peg Davis
  • Janice Oyarzo
  • Todd Vanderah
  • Josephine Lai
  • Frank Porreca
  • Ruben Vardanyan
  • Victor J. Hruby
Part of the Advances in Experimental Medicine and Biology book series (volume 611)

Keywords

Opioid Receptor Agonist Activity Opioid Activity Opioid Ligand Antiallodynic Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This work was supported by grants from the USDHS, National Institute on Health (DA12394 and DA06284).

References

  1. 1.
    Zhao, G-M, et al. J. Pharmacol. Exp. Ther. 302, 188–196 (2002).CrossRefGoogle Scholar
  2. 2.
    Horan, P. J., et al. J. Pharmacol. Exp. Ther. 265, 896–902 (1993).Google Scholar
  3. 3.
    Lee, Y.S., et al. Bioorg. Med. Chem. Lett. 17, 2161–2165 (2007).CrossRefGoogle Scholar
  4. 5.
    Lee, Y.S., et al. J. Med. Chem. 49, 1773–1780 (2006).CrossRefGoogle Scholar
  5. 6.
    Tetko, I. V., et al. J. Comput. Aid. Mol. Des. 19, 453–63 (2005).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • YeonSun Lee
    • 1
  • Ravil Petrov
    • 1
  • Vinod Kulkarni
    • 1
  • Byoung J. Min
    • 1
  • Shou-wu Ma
    • 2
  • Peg Davis
    • 2
  • Janice Oyarzo
    • 2
  • Todd Vanderah
    • 2
  • Josephine Lai
    • 2
  • Frank Porreca
    • 2
  • Ruben Vardanyan
    • 1
  • Victor J. Hruby
    • 1
  1. 1.Department of ChemistryUniversity of ArizonaTucsonUSA
  2. 2.Department of PharmacologyUniversity of ArizonaTucsonUSA

Personalised recommendations